Proeomics-based approaches, which examine the expressed proteins of a tissue or cell type,
complement the genome initiatives and are increasingly being used to address biomedical …

The assessment of angiogenesis in breast cancer is of importance as a key indicator of
survival and response to therapy. Circulating vascular endothelial growth factor (VEGF) …

Ovarian cancer is the fourth most common cancer in women in the Western world. In a pilot
scale study, we highlight changes in the total serum glycome of patients with advanced …

Despite recent developments in bottom‐up proteomics, the need still exists in a fast,
uncomplicated, and robust method for comprehensive sample processing especially when applied …

Exosomes are 40–100 nm vesicles released by numerous cell types and are thought to
have a variety of roles depending on their origin. Exosomes derived from antigen presenting …

Genetic and epigenetic changes in the von Hippel-Lindau (VHL) tumor suppressor gene
are common in sporadic conventional renal cell carcinoma (cRCC). Further insight into the …

The aim of this manuscript is to initiate a constructive discussion about the definition of
clinical proteomics, study requirements, pitfalls and (potential) use. Furthermore, we hope to …

We conducted a two-stage genome-wide association study of renal cell carcinoma (RCC) in
3,772 affected individuals (cases) and 8,505 controls of European background from 11 …

A primary objective of many protein expression studies is to define expression patterns that
can distinguish between normal and diseased states, enabling a better understanding of …

Proteomics‐based studies offer a powerful complementary approach to DNA/RNA‐based
investigations and are now being applied to investigate aspects of many diseases including …